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Background: Calibrated Automated Thrombography (CAT) has been widely used to assess in vitro thrombin
generation as an informative intermediary phenotype of coagulation. Interlaboratory exercises have documented
a worrisome poor reproducibility. There are some data on the normalisation with an appropriate external refer-
ence plasma (RP). This multicentre study of the French-speaking CAT Club aimed at providing further evidence
for the usefulness of such a normalisation.
Materials and Methods: Lyophilised aliquots of a RP along with 3 plasmas (P1 = normal; P2 = hypo-; P3 =
hypercoagulable) were sent to 34 laboratories (corresponding to 38 instruments). CAT was studied using 1
and 5 pM tissue factor and other dedicated reagents. Normalisation with the local RP in use in the laboratory
could also be performed. Interlaboratory CVs were calculated for each plasma before and after normalisation.
Results: Regarding endogenous thrombin potential, a good discrimination between the 3 plasmas was achieved
in all laboratories but therewas no overlap after normalisation only. CVswere generally not reducedwith the use
of local RP but were generally improved with normalisation using the external RP, often becoming lower thanémostase, CHU Nancy, rue du Morvan, 54511 Vandoeuvre les Nancy, France. Tel.: +33 3 83 15 51 92; fax: +33 3 83 15 37 89.
la Thrombose’, a working group of the French Society for Haematology.
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usefulness of normalisation with..., Thromb10%. Regarding P2 however, the beneﬁt of normalisation was poor, and there were analytical difﬁculties as well,
some laboratories being unable to get a useable signal.
Conclusions: We conﬁrm that normalisation of CAT results with a suitable external RP is useful in “real life”
practice as it often permits an acceptable level of interlaboratory variability. In case of frank hypocoagulability,
further improvements are required to get reliable, potentially clinically relevant results.© 2014 Published by Elsevier Ltd.Introduction
There has been a growing interest for thrombin generation tests
(TGTs) [1,2]. Such tests allow a comprehensive and potentially clinically
relevant in vitro phenotyping of blood coagulation. They take into
account thrombin generation beyond the physical phenomenon of
clotting as well as the entire process of thrombin inhibition as a whole,
allowing the detection and quantiﬁcation of both hypo- and hyper-
coagulable states.
Among TGTs, the method developed by Hemker et al., namely Cali-
brated Automated Thrombography (CAT) [3] has been extensively stud-
ied for the last decade since: (i) the use of a calibrator allows an accurate
measurement of the actual amounts and activities of generated throm-
bin; (ii) the detection of ﬂuorescent signals allows the measurement in
cellular milieus (except red blood cells), for instance platelet-rich
plasmas [4] or leucocyte-rich plasmas [5].
Data have been published with the CAT method, consistent with a
potentially high added value in clinical practice, in settings such as diag-
nosis and management of bleeding disorders [6–8], detection of hyper-
coagulability [9,10], characterization/monitoring of anticoagulant drugs
including non-vitamin K antagonist oral anticoagulants [11,12] or even
in acquired complex coagulation disorders [13]. Most of the data come
from single-centre studies and must be conﬁrmed in prospective,
large, multicentre studies. However the method still suffers from an
important inter-centre variability and a persistent deﬁciency in stan-
dardisation [14–17], which makes difﬁcult the design of multicentre
studies unless performing TGT in a centralised laboratory. Normalisation
of raw results using a normal plasma (pooled or lyophilised) has been
proposed for that purpose [14–18]. Recently, a standardized protocol
with normalisation of results using a reference plasma (RP) has been
shown to reduce lab-to-lab variability [19]. Though promising, such
data, obtained in a relatively small number of reference laboratories
and using a single batch of reagents, remain distant from real life prac-
tice. We report the largest multicentre study to date on lab-to-lab vari-
ability and improvement by normalisation of data using a single and
suitable externally provided RP.Materials and methods
Reagents
Reagents and lyophilised plasmas were supplied from Diagnostica
Stago (Asnières, France): PPP Reagent LOW™ and PPP Reagent™, Throm-
bin Calibrator™ and FLUCAkit™, aswell as 4 lyophilised plasmas - plasma
1 (“normocoagulable”); plasma 2 (“hypocoagulable” – heparinised plas-
ma); plasma 3 (“hypercoagulable” – plasma deﬁcient in protein S); and
external reference plasma (external RP) for normalisation of results.
This external reference plasma is a lyophilised plasma selected to have a
thrombin generation proﬁle as close as possible to a fresh frozen normal
donor plasma pool. It has been demonstrated to be suitable for such use
by Dargaud et al. [19].Fig. 1. Typical thrombin generation proﬁles of the 4 plasmas used in the study, obtained
with (A) 1 pM TF – PPP Reagent LOW™; (B) 5 pM TF – PPP Reagent™.Study design
The study aimed to evaluate in a large multicentre survey: (i) the
lab-to-lab variability of TGT using CAT method; (ii) the beneﬁt ofe external quality assessmen
Res (2014), http://dx.doi.org/normalisation of results using a lyophilised external RP and, depending
on the ongoing practice of each centre, the local reference plasma.
Each plasma (numbered 1, 2 and 3 as stated above) had to be tested
using CAT method in an independent run over 3 days. In parallel, the
reference plasma was studied in each run. Instructions were given to
participants regarding use of dedicated reagents, test plasma in tripli-
cates and adherence to manufacturer's instructions for plasma/reagent
reconstitution and CAT performance. No instruction was given regard-
ing preheating plates at 37 °C. Of note also, the locally implemented ver-
sion of Thrombinoscope™ software was used (2 different versions).
Thus 6 batches of initiating reagents (PPP Reagent™ and PPP Reagent
LOW™) were used; concerning Thrombin Calibrator™ and FLUCA
kit™, a single batch was provided, but each participant could use its
own reagent batch.t survey on thrombin generation with CAT: further evidence for the
10.1016/j.thromres.2014.12.015
Table 1
Robust means (see text) and associated lab-to-lab CVs with 1 pM TF as initiating condition (PPP Reagent LOW™). Bold characters indicate CVs≤ 10%. Symbols (↑, =, ↓) illustrate changes
in CVs as compared with raw data. Normalised results are expressed as a percentage of a RP, except for temporal data (lag time, start tail and time to peak) which are expressed as ratios.
Parameters Raw data Normalised data
Local plasma
Normalised data
External reference plasma
Robust mean CV Robust mean CV Robust mean CV
Plasma 1 ETP 1167 nM.min 17% 122% 28% ↑ 98% 10% ↓
Lag time 3.6 min 15% 0.79 17% ↑ 0.68 8% ↓
Peak 108 nM 21% 118% 42% ↑ 87% 17% ↓
Start tail 34.5 min 9% 1.1 16% ↑ 1.08 9% =
Time to peak 9.0 min 9% 0.93 12% ↑ 0.89 7% ↓
Velocity index 20 nM/min 29% 113% 50% ↑ 77% 27% ↓
Plasma 2 ETP 119 nM.min 38% 11% 41% ↑ 10% 56% ↑
Lag time 3.8 min 31% 0.92 32% ↑ 0.77 21% ↓
Peak 5 nM 35% 5% 43% ↑ 4% 42% ↑
Start tail 52.5 min 17% 1.6 32% ↑ 1.6 26% ↑
Time to peak 15.7 min 18% 1.7 23% ↑ 1.6 12% ↓
Velocity index 0.43 nM/min 46% 2% 53% ↑ 2% 43% ↓
Plasma 3 ETP 1929 nM.min 16% 187% 26% ↑ 156% 9% ↓
Lag time 3.2 min 13% 0.70 19% ↑ 0.60 6% ↓
Peak 440 nM 10% 444% 50% ↑ 336% 18% ↑
Start tail 22.3 min 12% 0.68 20% ↑ 0.68 12% =
Time to peak 4.9 min 10% 0.52 18% ↑ 0.48 6% ↓
Velocity index 247 nM/min 15% 1421% 67% ↑ 937% 34% ↑
3J. Perrin et al. / Thrombosis Research xxx (2014) xxx–xxxThrombin generation test and data analysis
Brieﬂy, 80 μL plasma samples were mixed with 20 μL initiating
reagent (PPP Reagent™ or PPP Reagent LOW™) in a 96-well plate.
Coagulation was started by adding 20 μL FLUCA kit™ containing calcium
chloride and theﬂuorogenic substrate (Z-Gly-Gly-Arg-AMC). Upon split-
ting by thrombin, the ﬂuorescent AMC (7-amino-4-methylcoumarin)
is released and measured with a 390-nm-excitation and a 460-nm-
emission ﬁlter set in an Ascent Fluoroskan™ (ThermoLabsystems,
Helsinki, Finland). All samples were run in triplicate. For each plasma
sample, the ﬂuorescence signal was corrected for substrate consump-
tion, plasma colour variability and inner ﬁlter ﬂuorescence effect by
running in parallel 3 calibrating wells where 80 μL plasma were mixed
with 20 μL Thrombin Calibrator™. As mentioned above, data were
analysed using the locally used version of Thrombinoscope™ software
(Diagnostica Stago – Asnières, France).
The following thrombin generation parameters were studied: en-
dogenous thrombin potential (ETP); lag time; thrombin peak; time to
peak; velocity index; start tail. Once performed, participants had to
enter the data in the Qualiris by Stago® website. This on-line platformTable 2
Robustmeans (see text) and associated lab-to-lab CVswith 5 pMTF as initiating condition (PPP
as compared with raw data. Normalised results are expressed as a percentage of a RP, except f
Parameters Raw data Extern
Local
Robust mean CV Robus
Plasma 1 ETP 1467 nM.min 15% 114%
Lag time 2.2 min 13% 0.
Peak 264 nM 19% 121%
Start tail 22.4 min 10% 0.
Time to peak 5.0 min 12% 0.
Velocity index 95 nM/min 32% 139%
Plasma 2 ETP 567 nM.min 22% 46%
Lag time 3.0 min 19% 1.
Peak 38 nM 37% 18%
Start tail 38.8 min 17% 1.
Time to peak 10.7 min 13% 1.
Velocity index 5.0 nM/min 54% 8%
Plasma 3 ETP 2079 nM.min 18% 155%
Lag time 2.0 min 15% 0.
Peak 468 nM 9% 202%
Start tail 22.0 min 15% 1.
Time to peak 3.6 min 12% 0.
Velocity index 283 nM/min 14% 417%
Please cite this article as: Perrin J, et al, Large external quality assessmen
usefulness of normalisation with..., Thromb Res (2014), http://dx.doi.org/collects all the results and provides laboratories with comparative re-
ports including, for each parameter, the “robust mean” calculation (sta-
tisticalmethodnot affected by outliers, see ISO Standard 13528). Results
are expressed in standardunits (raw result), as a percentage or as a ratio
of external or local reference plasma (“normalised result”). Lab-to-lab
coefﬁcients of variation (CV) were then determined for both raw and
normalised results with the 3 assayed plasmas.
Results
Typical thrombin generation proﬁles of the 4 plasmas are shown in
Fig. 1.
Thirty-four participants sent data corresponding to 38 CAT instru-
ments; among them, 21 centres sent data using their local reference
plasma in addition to the external reference plasma.
Raw data & lab-to-lab variability
Under both initiating conditions (1 or 5 pM TF) and with the 3
plasmas, lab-to-lab variability was important (Tables 1 and 2), mostReagent™). Bold characters indicate CVs≤ 10%. Symbols (↑, =, ↓) illustrate changes in CVs
or temporal data (lag time, start tail and time to peak,) which are expressed as a ratio.
al reference plasma
plasma
Normalised data
External reference plasma
t mean CV Robust mean CV
10% ↓ 94% 8% ↓
82 13% = 0.77 9% ↓
20% ↑ 99% 10% ↓
99 8% ↓ 0.93 6% ↓
87 12% = 0.86 8% ↓
33% ↑ 105% 18% ↓
18% ↓ 36% 20% ↓
16 16% ↓ 1.08 9% ↓
31% ↓ 14% 39% ↑
68 14% ↓ 1.63 15% ↓
84 16% ↑ 1.86 10% ↓
43% ↓ 6% 52% ↓
14% ↓ 129% 8% ↓
73 9% ↓ 0.70 8% ↓
28% ↑ 172% 14% ↑
00 14% ↓ 0.91 8% ↓
62 16% ↑ 0.62 8% ↓
58% ↑ 306% 28% ↑
t survey on thrombin generation with CAT: further evidence for the
10.1016/j.thromres.2014.12.015
Fig. 2. ETP as raw and normalised results with external RP, obtained with (A) TF 1 pM – PPP Reagent LOW™ (B) TF 5 pM – PPP Reagent™.
4 J. Perrin et al. / Thrombosis Research xxx (2014) xxx–xxxCVs being higher than 10% for almost all parameters, some values even
exceeding 20%. As an example, regarding ETP, CVs were comprised be-
tween 15 and 35 %. Of note, dispersion of data was more important
with plasma 2 or at low TF concentration. In addition, the velocity
index stood as the most variable parameter, the CVs being almost
always the highest of the series, except for plasma 3.
Normalisation with the local reference plasma
Using the local reference plasma, lab-to-lab variability was still
important, as only few CVs fell below 10%, whatever TF concentrations
or plasmas. Some CVs were even higher than before normalisation; at
low TF concentration, normalisation consistently worsened CVs.
Normalisation with external RP
Except for plasma 2, for which there were analytical difﬁculties as
well (3 laboratories being unable to get a useable signal) and whatever
the TF concentration, normalisation of resultswith external RP obviously
generally improved interlaboratory CVs. Noteworthy, for a given param-
eter, CVs after normalisation, when improved, often decreased below
10%. Furthermore, regarding ETP, even if a good discrimination of the 3
plasmaswas achieved in all laboratories, theoverlapwas only eliminated
after normalisation (an outlier value persisting with plasma 3) (Fig. 2).
Regarding the “thrombin peak”with plasma 3however, CV after normal-
isation was higher than before (18% versus 10% at 1 pM TF). Besides, the
normalisationwas of poor beneﬁtwith someparameters, themore so re-
garding velocity index, with equal or higher CVs under both TF condi-
tions, with the 3 plasmas.
Discussion
We report the largest study to date regarding thrombin generation
with CAT, in terms of number of participants and analysed parameters,
on lab-to-lab variability and potential beneﬁt of results normalisation
using an external RP. As an example, the European external assessmentPlease cite this article as: Perrin J, et al, Large external quality assessmen
usefulness of normalisation with..., Thromb Res (2014), http://dx.doi.org/program ECAT 2013–2 exercise gathered 15 and 20 participants with 1
pM or 5 pM TF as coagulation initiating conditions respectively (see
ECAT External quality Control for Assays and Tests foundation, report
2013–02 Thrombin Generation Test).
Three kinds of plasmas were chosen to cover the whole spectrum of
thrombin generation measuring range, markedly hypocoagulable,
normocoagulable and highly hypercoagulable, as compared to data ob-
tained in healthy subjects under similar conditions [18,20]. For practical
purposes itwas decided for defective coagulation to supplement normal
plasmawith heparin. Plasma artiﬁcially depleted in protein Swas found
to be hypercogulable due at least in part to the expected loss of APC-
independent anticoagulant effect [21,22]. In agreement with previously
published data [19] and ECAT TGT surveys, the lab-to-lab variability of
raw results was important whatever the initiating conditions or types
of plasma. Indeed, only few CVs were inferior to 10%, a maximal accept-
ed target-value to allow multicentre studies. The variability was more
important at low TF concentration or with the hypocoagulable plasma.
In a previousmulticentre study (5 participants), Dargaud et al. reported
a better improvement in CVs than in the present work, under similar
initiating conditions (1 pM TF). However, the design of the previous
study signiﬁcantly differed by using a single batch of reagents and
frozen plasmas; plasmas were prepared using corn trypsin inhibitor
(to eliminate the variable contribution of the contact phase) and were
less hypo- or hyper-coagulable.
In the present study, the fact that CVs for ETP (often considered as
the most global and important parameter of CAT) were often higher
than 15% raises somequestions on differences in real-life local practices,
since all participants were familiar with themethod. As a matter of fact,
even if the experimentation protocol was standardised, some local ex-
perimental variability is likely to have existed, regarding factors such
as the pre-heating or not of samples and/or plates beforemeasurement,
or even the reconstitution of reagents and plasmas (the latter being
probably more subject to variability than thawing of frozen plasma).
To reduce lab-to-lab variability, normalisation of raw data with an
appropriate plasma has been proposed [14,15,19]. In the herein report-
ed study, participants had to normalise their data with external RPt survey on thrombin generation with CAT: further evidence for the
10.1016/j.thromres.2014.12.015
5J. Perrin et al. / Thrombosis Research xxx (2014) xxx–xxxprepared by Diagnostica Stago and, if applicable, the locally prepared
pool of normal plasma.
Strikingly, the local plasma was generally unable to improve lab-to-
lab variability whatever the initiating conditions or plasma, even wors-
ening CVs after normalisation. This may be related to the disparities in
preparation modalities (sampling, centrifugation, pooling…), as it is
accepted that preanalytical treatment largely inﬂuences TGT [16].
Therefore, the main interest of such a material is essentially to act as
an “internal quality control” to minimise run-to-run intralaboratory
variability. Thus a suitable, well-characterised, external referencemate-
rial is needed.
Normalisation with external RP generally improved CVs, which
often dropped below 10% for plasma 1 and 3. In particular, CVs for
normalised ETP were acceptable, except for plasma 2. More generally,
regarding the markedly hypocoagulable plasma 2, normalisation with
RP had poor impact on CVs since the values obtained are at the very
low end of the CAT measuring range. Surprisingly, for unclear reasons,
normalisation with RP worsened CVs for thrombin peak with the
hypercoagulable plasma, under both initiating conditions. Interestingly,
despite an outlier value persisting with plasma 3, normalised ETPs
allowed a better discrimination of the 3 plasmas at the multicentre
scale, where raw ETPs overlapped. This appears very encouraging for
the design of large-scale studies.
Our results also highlight that variability is important andnot or only
poorly corrected by normalisation. This is especially the case for velocity
index. An explanation would be that this parameter is calculated using
lag time, time to peak and peak, therefore cumulating variability of
each individual parameter. Furthermore, the peak is derived from the
ﬁrst derivative of the ﬂuorescent signal, and the noise in a derivative
is always higher than in the original signal; thus it is expected that
this parameter and those based on it have a high variability. Several con-
cerns have been raised with plasma 2, some centres being unable to get
a useable increase in ﬂuorescence or reporting a ‘0 nM.min’ result for
ETP. This is a problem because in case of frank hypocoagulability, tiny
thrombin generation might be of clinical importance compared to no
generated thrombin at all [23,24]. The reasons for this discrepancy
between centres are unclear; further improvements are required to
get reliable results. The poor results obtained with plasma 2 (markedly
hypocoagulable) may also be due to the noise of the ﬂuorescent signal,
the impact of which is proportionally more important at low signals, in
particular for the determination of the tail of the curve (“start tail”), and
this ultimately affects the shape of the ﬁnal, α2M-corrected thrombin
generation curve [25].
Calibration andnormalisation combine their effects to reduce lab-to-
lab variability. On onehand the use of a calibrator allows to reduce some
technical aspects like plasma colour and optical factors (ﬁlters, lamp…)
[26]. On the other hand, normalisation is very likely to correct batch-to-
batch variability of reagents; in addition, it may correct some analytical
aspects such as measurement temperature, the pre-heating or not of
plates, which is critical [27], or the operator-related variability (recon-
stitution of reagents or dispensing).
To go one step further, it is interesting to note that the improvement
of CVs is the clearest for plasma 1,which is normal, possibly because the
external RP has a normal proﬁle as well. The hypothesis that normalisa-
tion with a RP close to the studied thrombin generation proﬁle (that is,
hypocoagulable RP for hypocoagulable samples; hypercoagulable RP
for hypercoagulable ones) would be more successful deserves to be
studied.
To conclude, we conﬁrm with the largest multicentre study to date
that normalisation of CAT results with a suitable external reference
plasma (RP) – which will be commercially available soon - is useful in
“real life” practice, with acceptable levels of variability. However, in
case of frank hypocoagulability, further improvements are required. In
addition, the next step should include different kinds and/or levels of
hypo- and hyper-coagulability to conﬁrm the suitability of RP to cover
the whole spectrum of thrombin generation disorders. Moreover, inPlease cite this article as: Perrin J, et al, Large external quality assessmen
usefulness of normalisation with..., Thromb Res (2014), http://dx.doi.org/order to further reduce interlaboratory variability, a strict adherence
to a well-deﬁned detailed experimental scheme seems also mandatory.
Our data suggest that lab-to-lab normalisation using a common and
suitable material could facilitate the design of multicentre studies,
allowing TGT to be locally performed in each participating centre.Conﬂict of interest
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